A modular vaccine platform merging the rapid development of genetic vaccines with the immunogenicity of virus-like particles

Adam F. Sander; Cyrielle Fougeroux

doi:10.1002/ctm2.70560

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (12) :e70560 DOI: 10.1002/ctm2.70560

INVITED LETTER

A modular vaccine platform merging the rapid development of genetic vaccines with the immunogenicity of virus-like particles

Adam F. Sander ¹^,²
, Cyrielle Fougeroux ²

Author information +

History +

PDF

Cite this article

Download citation ▾

Adam F. Sander, Cyrielle Fougeroux. A modular vaccine platform merging the rapid development of genetic vaccines with the immunogenicity of virus-like particles. Clinical and Translational Medicine, 2025, 15(12): e70560 DOI:10.1002/ctm2.70560

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Lee IT, Nachbagauer R, Ensz D, et al. Safety and immunogenicity of a phase 1/2 randomized clinical trial of a quadrivalent, mRNA-based seasonal influenza vaccine (mRNA-1010) in healthy adults: interim analysis. Nat Commun. 2023; 14: 3631.

[2]	Roe MD, Coggins SA, Darcey ES, et al. Estimating the decay of protective antibodies induced by SARS-CoV-2 mRNA vaccination and hybrid immunity. npj Viruses. 2025; 3: 76.

[3]	Soucheray S. Moderna reports RSV vaccine 50% effective after 18 months. 2024. Assessed Agust 12, 2024. https://www.cidrap.umn.edu/respiratory-syncytial-virus-rsv/moderna-reports-rsv-vaccine-50-effective-after-18-months

[4]	Porras C, Romero B, Kemp T, et al. HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial. J Natl Cancer Inst Monogr. 2024; 2024(67): 329-336.

[5]	Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010; 10: 787-796.

[6]	Thrane S, Janitzek CM, Matondo S, et al. Bacterial superglue enables easy development of efficient virus-like particle based vaccines. J Nanobiotechnol. 2016; 14: 30.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.